USANA Health Sciences, Inc.
USNA
$27.27
-$0.28-1.02%
NYSE
| 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.75% | -2.69% | -7.22% | -7.10% | -7.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.75% | -2.69% | -7.22% | -7.10% | -7.67% |
| Cost of Revenue | 7.24% | -0.38% | -8.76% | -8.75% | -8.97% |
| Gross Profit | 1.69% | -3.23% | -6.86% | -6.70% | -7.36% |
| SG&A Expenses | 6.43% | 1.57% | -3.73% | -6.26% | -6.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.61% | 1.16% | -4.80% | -6.80% | -7.12% |
| Operating Income | -33.36% | -36.94% | -28.74% | -9.92% | -12.54% |
| Income Before Tax | -31.62% | -34.71% | -25.48% | -6.20% | -6.79% |
| Income Tax Expenses | -24.40% | -20.33% | -11.31% | -1.64% | 3.79% |
| Earnings from Continuing Operations | -36.78% | -43.80% | -34.06% | -9.15% | -13.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.06% | -43.67% | -34.11% | -9.15% | -13.12% |
| EBIT | -33.36% | -36.94% | -28.74% | -9.92% | -12.54% |
| EBITDA | -18.10% | -25.53% | -23.55% | -8.33% | -11.14% |
| EPS Basic | -37.13% | -43.14% | -33.55% | -8.57% | -12.75% |
| Normalized Basic EPS | -31.84% | -33.99% | -24.89% | -5.58% | -6.38% |
| EPS Diluted | -37.24% | -43.46% | -33.79% | -8.50% | -12.70% |
| Normalized Diluted EPS | -31.61% | -33.81% | -24.90% | -5.52% | -6.54% |
| Average Basic Shares Outstanding | -1.30% | -0.89% | -0.87% | -0.69% | -0.44% |
| Average Diluted Shares Outstanding | -1.66% | -1.19% | -0.95% | -0.77% | -0.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |